Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yusaku Shirai"'
Autor:
Hideto Kawaratani, Tatsuhiro Tsujimoto, Norihisa Nishimura, Tomoyasu Taniguchi, Yusaku Shirai, Kenichi Kin, Masaki Nakayama, Hisao Fujii, Hiroshi Fukui
Publikováno v:
Case Reports in Gastroenterology, Vol 5, Iss 2, Pp 404-410 (2011)
We report herein the case of a lobulated and pedunculated hyperplastic polyp in the third portion of the duodenum causing anemia and occult blood in stools, which was detected by capsule endoscopy (CE) and treated with snare polypectomy. A 71-year-ol
Externí odkaz:
https://doaj.org/article/f7eef6f632c74e8fa390786ee4b877cb
Autor:
Tadashi Namisaki, Kosuke Kaji, Yusaku Shirai, Ryuichi Noguchi, Kei Moriya, Yosuke Aihara, Akitoshi Douhara, Hideto Kawaratani, Hiroshi Fukui, Hitoshi Yoshiji
Publikováno v:
Journal of Gastroenterology and Hepatology. 28:723-730
Background and Aim The innate immune system, including toll-like receptor-4 (TLR4) signaling cascade and angiotensin-II (AT-II) play important roles in the progression of liver fibrosis development; the cross talk between TLR4 and AT-II has not been
Autor:
Yasuhide Ikenaka, Hiroshi Fukui, Yusaku Shirai, Mitsuteru Kitade, Akitoshi Douhara, Kosuke Kaji, Kei Moriya, Tadashi Namisaki, Koji Yanase, Hitoshi Yoshiji, Yosuke Aihara, Ryuichi Noguchi, Hideto Kawaratani, Junichi Yoshii
Publikováno v:
Journal of Gastroenterology. 49:481-491
Dipeptidyl peptidase-4 inhibitor (DPP4-I) is clinically used as a new oral antidiabetic agent. Although DPP4 is reportedly associated with the progression of chronic liver diseases, the effect of DPP4-I on liver fibrosis development is still obscure.
Autor:
Yosuke Aihara, Ryuichi Noguchi, Hiroshi Fukui, Kosuke Kaji, Kei Moriya, Yasuhide Ikenaka, Hitoshi Yoshiji, Yusaku Shirai, Akitoshi Douhara, Tadashi Namisaki, Mitsuteru Kitade
Publikováno v:
Hepatology Research. 43:765-774
Aim Both angiotensin-II (AT-II) and aldosterone (Ald) play pivotal roles in the pathogenesis of diseases in several organs including the liver. We previously reported that suppression of AT-II and Ald with angiotensin-converting enzyme inhibitor (ACE
Autor:
Koji Yanase, Junichi Yoshii, Tatsuhiro Tsujimoto, Kosuke Kaji, Yasuhide Ikenaka, Mitsuteru Kitade, Ryuichi Noguchi, Yusaku Shirai, Tadashi Namisaki, Hitoshi Yoshiji, Hiroshi Fukui, Yosuke Aihara, Hideto Kawaratani
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 300:G1094-G1104
Angiotensin II type I receptor blocker and iron chelator reportedly exert suppressive effects on nonalcoholic steatohepatitis (NASH) progression, including liver fibrosis and hepatocarcinogenesis. The aim of this study was to elucidate the combined e
Autor:
Hiroshi Fukui, Norihisa Nishimura, Yusaku Shirai, Hideto Kawaratani, Hisao Fujii, Masaki Nakayama, Tatsuhiro Tsujimoto, Kenichi Kin, Tomoyasu Taniguchi
Publikováno v:
Case Reports in Gastroenterology
Case Reports in Gastroenterology, Vol 5, Iss 2, Pp 404-410 (2011)
Case Reports in Gastroenterology, Vol 5, Iss 2, Pp 404-410 (2011)
We report herein the case of a lobulated and pedunculated hyperplastic polyp in the third portion of the duodenum causing anemia and occult blood in stools, which was detected by capsule endoscopy (CE) and treated with snare polypectomy. A 71-year-ol
Autor:
Hiroshi Fukui, Chie Morioka, Masahisa Toyohara, Ryuichi Noguchi, Hideto Kawaratani, Junichi Yamao, Yusaku Shirai, Kosuke Kaji, Masao Fujimoto, Hitoshi Yoshiji, Masahito Uemura, Tatsuhiro Tsujimoto, Akira Mitoro, Motoyuki Yoshida, Yosuke Aihara, Yasuhide Ikenaka, Masayoshi Sawai
Publikováno v:
Oncology Letters. 2:69-73
The identification of biomarkers of anti-angiogenic therapy that predict clinical benefit is of vital importance. We previously reported that a combination treatment with clinically available safe agents, specifically angiotensin-converting enzyme in
Autor:
Hiroshi Fukui, Kosuke Kaji, Mitsuteru Kitade, Yasuhide Ikenaka, Tadashi Namisaki, Hideto Kawaratani, Hitoshi Yoshiji, Tatsuhiro Tsujimoto, Masaharu Yamazaki, Ryuichi Noguchi, Yusaku Shirai, Koji Yanase, Junichi Yoshii
Publikováno v:
Hepatology Research. 40:540-549
Aim The renin-angiotensin-aldosterone system (RAAS) has become known as a prerequisite for tumor angiogenesis, including hepatocellular carcinoma (HCC). Although angiotensin II is known to play an important role in tumor growth and angiogenesis, the
Autor:
Tatsuhiro Tsujimoto, Ryuichi Noguchi, Kosuke Kaji, Yusaku Shirai, Hitoshi Yoshiji, Yasuhide Ikenaka, Tadashi Namisaki, Mitsuteru Kitade, Hiroshi Fukui, Hideto Kawaratani
Publikováno v:
Journal of Gastroenterology. 45:443-450
Insulin resistance (IR) is reportedly involved in the progression of hepatocellular carcinoma (HCC). Because neovascularization plays an important role in HCC, including hepatocarcinogenesis, an angiostatic therapy would be a promising approach for c
Autor:
Hitoshi Yoshiji, Hideto Kawaratani, Fumi Kawanami, Kousaku Morita, Tatsuhiro Tsujimoto, Hiroshi Fukui, Masaaki Yoshikawa, Yusaku Shirai
Publikováno v:
Journal of Medical Case Reports
Introduction Large cell neuroendocrine carcinoma in the salivary glands is rare. We report a second case of large cell neuroendocrine carcinoma of the submandibular gland diagnosed at autopsy, and a review of the literature. Case presentation A 68-ye